您好,欢迎来到科研在线!科研采购 · 选型 · 实验方法
首页产品库品牌馆产品类别品牌新闻会议会展产品试用求职招聘资讯专题教程
REA / Bioactive Compounds

Recombinant human IL-33 Protein

Recombinant human IL-33 Protein

英诺赛图(InnoCyto)的 Recombinant human IL-33 Protein,属于生物活性物质,靶点/物种 IL-33(别名 IL-1F11),表达宿主 E.coli,纯度 ≥95%(SDS-PAGE),适用于生物活性检测。提供 5 μg、100 μg 规格,目录价 ¥678 起,仅供科研使用(RUO)。

科学仪器 供应商 上海英诺赛图 ↗ 型号 632101 更新 2026-11-12
参考价格区间
¥678
含税参考价,实际以配置与渠道报价为准
本条目供应商 上海英诺赛图原厂 1865个条目 进入企业主页

01产品图片

02产品简介

英诺赛图(InnoCyto)的 Recombinant human IL-33 Protein,属于生物活性物质,靶点/物种 IL-33(别名 IL-1F11),表达宿主 E.coli,纯度 ≥95%(SDS-PAGE),适用于生物活性检测。提供 5 μg、100 μg 规格,目录价 ¥678 起,仅供科研使用(RUO)。

03产品介绍

规格与货号

632101 | 5 μg | ¥678

632102 | 100 μg | ¥5,288

Product Details

Sources|A DNA sequence encoding the C-terminal segment of human IL33 (NP_254274.1) (Ser 112-Thr 270) was expressed with an initial Met at the N-terminus.

Molecular Weight|The recombinant human IL33 comprises 160 amino acids and predicts a molecular mass of 18 kDa as estimated in SDS-PAGE under reducing conditions.

Regulatory Status|RUO

Endotoxin level

Protein Concentration|Lyophilized

Storage and Handling|Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

Background Information

Interleukin-33 (IL-33) is a member of the interleukin-1 (IL-1) cytokine family and functions as both a cytokine and an intracellular nuclear factor. It is constitutively expressed by epithelial cells, endothelial cells, fibroblasts, and other structural cells, where it serves as an "alarmin" that is rapidly released following tissue injury or cellular stress. Once released, IL-33 alerts the immune system to tissue damage and promotes both innate and adaptive immune responses.

Human IL-33 is synthesized as a 270-amino acid precursor protein with an N-terminal nuclear localization domain and a C-terminal IL-1-like cytokine domain. Unlike many cytokines, full-length IL-33 is biologically active, although its activity can be modified by proteolytic processing. Its primary receptor is ST2 (IL1RL1), which forms a signaling complex with the co-receptor IL-1 receptor accessory protein (IL-1RAcP). Binding of IL-33 to ST2 activates MyD88-dependent signaling pathways, leading to NF-κB and MAP kinase activation and the production of inflammatory mediators.

IL-33 plays a central role in type 2 immune responses by activating type 2 innate lymphoid cells (ILC2s), mast cells, eosinophils, basophils, Th2 cells, and regulatory T cells. Dysregulated IL-33 signaling has been implicated in numerous diseases, including asthma, allergic rhinitis, atopic dermatitis, chronic obstructive pulmonary disease, inflammatory bowel disease, rheumatoid arthritis, cardiovascular disease, and certain cancers, where its effects may either promote anti-tumor immunity or support tumor progression depending on the tumor microenvironment.

Because of its broad involvement in inflammatory diseases, the IL-33/ST2 signaling axis has become an attractive therapeutic target. Monoclonal antibodies targeting IL-33 (such as itepekimab and tozorakimab) or its receptor ST2 are currently being evaluated in clinical trials for asthma, COPD, and other inflammatory disorders. These therapies aim to suppress excessive type 2 inflammation while preserving normal immune function, making IL-33 an important target for next-generation immunomodulatory treatments.

04完整参数表

参数由厂商资料整理,采购前请以最终报价单与技术协议为准。

包装规格5 μg
ApplicationBioassay
FormatLyophilized from sterile PBS, pH 7.4.
Expression HostE.coli
Target NameIL-33, IL-1F11
SpeciesHuman
accession numberNP_254274.1
Affinity TagNone
Purity≥ 95 % as determined by SDS-PAGE. ≥ 90 % as determined by SEC-HPLC. ≥ 90 % as determined by SEC-MALS(Routinely tested).
Regulatory StatusRUO
Protein ConcentrationLyophilized
目录价¥678

05荣誉与资质

该品牌暂未上传荣誉证书与资质文件。以下是平台可核验的公开信息,未上传项如实标注,不做推断。

  • 营业执照未上传
  • 品牌授权未上传
  • 产品检测报告未上传
会员身份
收费会员
经营身份
原厂
成立年份
2020 年
所在地
上海
收录条目
1865 个
平台核验
平台代管
向品牌方索取资质文件

06品牌与供应商

上海英诺赛图 原厂
InnoCyto

以可信赖的细胞研究试剂,助力科研突破

进入企业主页
1865 本目录条目
产地 / 总部上海市浦东新区
成立年份2020 年
本目录主营生化试剂 / 蛋白与抗体

InnoCyto(上海英诺赛图生物科技有限公司)致力于通过开发高质量细胞分析试剂,加速科学发现进程。公司为研究人员提供细胞层面探索所需的工具,推动免疫学、肿瘤学等多领域的研究创新。 核心团队拥有丰富的行业经验,曾参与全球头部生命科学公司的标杆项目搭建,深刻理解工业界与学术研究的前沿需求。试剂从设计之初即以精确性、一致性、高性能为核心标准,让科学家能把精力集中在最核心的研究工作上。 公司将深厚的科学积累与对品质的严格承诺相结合,力争成为全球研究人员信赖的合作伙伴。产品线覆盖经验证的一抗与二抗、同型对照、生物类似药抗体、重组蛋白、细胞因子、免疫检测试剂盒及配套试剂,并提供重组蛋白/抗体表达与标记偶联服务。

售后与服务

品牌资料由厂商公开信息与授权渠道核对整理;条目参数与价格以最终报价单为准。

引用此条目 产品目录 · 更新于 2026-11-12
科研在线(TeleVM). Recombinant human IL-33 Protein(632101)[EB/OL]. 产品目录, 2026-11-12. https://www.suprotek.cn/products/item/recombinant-human-il-33-protein.html.
TeleVM. (2026, November 12). Recombinant human IL-33 Protein(632101). 产品目录. https://www.suprotek.cn/products/item/recombinant-human-il-33-protein.html
@misc{biocsp_item_recombinant_human_il_33_protein,
  title        = {Recombinant human IL-33 Protein(632101)},
  author       = {{科研在线}},
  year         = {2026},
  howpublished = {产品目录},
  note         = {更新于 2026-11-12,产品目录},
  url          = {https://www.suprotek.cn/products/item/recombinant-human-il-33-protein.html}
}

GB/T 7714 用于中文论文与报告;APA 7 用于英文期刊;BibTeX 可直接导入 Zotero、EndNote 或 LaTeX。

许可:CC BY-NC 4.0 · 转载注明来源
获取正式报价

Recombinant human IL-33 Protein

提交后由平台转给品牌方,通常 1 个工作日内联系。不需要注册。